Axonics Announces First Patients Treated in Sacral Neuromodulation Study
Irvine, California (ots/PRNewswire) - Post-market Clinical Study Evaluates Axonics Miniaturized, Rechargeable System for Overactive Bladder Patients Axonics Modulation Technologies, Inc., the developer of the first rechargeable implantable Sacral Neuromodulation (SNM) System for the treatment of urinary and fecal dysfunction, announced today that its first patients ...
plus